During the past decade, Evangelisches Krankenhaus Kalk conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evangelisches Krankenhaus Kalk" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Dr. Falk Pharma GmbH" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Tigenix S.A.U." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelisches Krankenhaus Kalk" #1 collaborator was "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Evangelisches Krankenhaus Kalk" are "Crohn's Disease" (2 trials), "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Cardiac Arrhythmias" (1 trials) and "Cardiac Death" (1 trials). Many other conditions were trialed in "Evangelisches Krankenhaus Kalk" in a lesser frequency.

Most popular intervention types in "Evangelisches Krankenhaus Kalk" are "Drug" (5 trials), "Device" (4 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Budesonide 2 mg suppository" (1 trials), "Budesonide 2 mg suppository/Mesalazine 1 g suppository" (1 trials), "Budesonide 4 mg suppository" (1 trials) and "Confirm Rx ICM insertion procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Evangelisches Krankenhaus Kalk" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Evangelisches Krankenhaus Kalk". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Evangelisches Krankenhaus Kalk, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Evangelisches Krankenhaus Kalk, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".